SCHEMBL14740754

SCHEMBL14740754

O=C(O)Nc1ccc(Br)cc1NC(=O)CC(=O)N1C=NC=CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
GAA P10253 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
NPC1 O15118 2/20 0.36
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 3/20 0.33
MAPT P10636 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
AAK1 Q2M2I8 1/20 0.33
MAPK1 P28482 2/20 0.32
PKM P14618 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
GRK2 P25098 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14740755 0.76 ALDH1A1 (0.37) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL14053110 0.71 ALDH1A1 (0.47) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL14740818 0.66 STING1 (0.42) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL14740843 0.64 KMT2A (0.53) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL17336575 0.64 RAB9A (0.43) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL12479615 0.60 MAPK1 (0.56) ALDH1A1GAAKMT2AMEN1TDP1
SCHEMBL9416712 0.60 MAPT (0.60) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL30894835 0.60 MAPT (0.60) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL3440627 0.60 ALDH1A1 (0.59) ALDH1A1GAAKMT2AMEN1NPC1
SCHEMBL22394778 0.60 MEN1 (0.51) GAAKMT2AMEN1NPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2751095-A2 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF Sanford-Burnham Medical Research Institute (US) 2014-07-09 EP disclosed
WO-2013033246-A2 NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF BRAINCELLS, INC. (US) 2013-03-07 WO disclosed